Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
1.
JAR Life ; 10: 50-53, 2021.
Article in English | MEDLINE | ID: mdl-36923515

ABSTRACT

The lockdown restrictions imposed as a result of COVID-19 impacted on many areas of daily life including dietary behaviours. A cohort of middle-older age adults (n=17), who had previously provided 3-day food diaries in May 2019 were asked to record their 3 day dietary intake in May 2020 when the UK was under lockdown restrictions. Mean (SD) energy intakes were significantly higher by ~750kilojoules in 2020 (8587kJ (1466.9)) compared to 2019 (7837 kJ (1388.9)). This energy increase is equivalent to ~170kcal; approximately 2 slices of bread. Furthermore, recorded meat/meat products, riboflavin, vitamin B6/B12 and iron intakes were all greater in 2020. No other dietary differences were observed between the two timepoints. This was a small, homogenous but well controlled sample, who exhibited a relatively stable diet during lockdown compared with pre-pandemic intakes 12 months earlier. It can be concluded that there was little evidence of food insecurity in this cohort.

2.
J Hum Nutr Diet ; 33(6): 822-832, 2020 12.
Article in English | MEDLINE | ID: mdl-32951269

ABSTRACT

BACKGROUND: The present study assessed the quantity and quality of nutritional advice and support given to colorectal cancer survivors in the UK. METHODS: A descriptive cross-sectional survey was completed by 75 colorectal cancer survivors recruited through social media and bowel cancer support groups in the UK. The survey consisted of open-ended and closed questions that aimed to explore the nutritional needs, nutritional advice given and other sources of information accessed by colorectal cancer survivors. RESULTS: Sixty-nine percent of respondents reported that they did not receive any nutritional advice or support from their healthcare team throughout diagnosis, treatment and post-treatment. Colorectal cancer survivors accessed nutritional advice from a variety of sources, mainly cancer charity websites. Respondents expressed their desire for individualised advice relating to their nutritional problems. CONCLUSIONS: The results obtained in the present study indicate that a high proportion of colorectal cancer patients are not receiving the nutritional support that they need to overcome nutritional difficulties. There is an urgent need to improve clinical practice to ensure colorectal patients receive nutritional advice that is both consistent between healthcare professionals and personalised throughout each stage of diagnosis, treatment and post-treatment.


Subject(s)
Cancer Survivors/psychology , Colorectal Neoplasms/diet therapy , Counseling , Nutrition Therapy/psychology , Patient Acceptance of Health Care/psychology , Adult , Aged , Aged, 80 and over , Colorectal Neoplasms/psychology , Cross-Sectional Studies , Female , Health Services Needs and Demand , Humans , Male , Middle Aged , Nutrition Therapy/methods , Qualitative Research , Surveys and Questionnaires , United Kingdom
3.
Nutr Bull ; 43(1): 97-102, 2018 03.
Article in English | MEDLINE | ID: mdl-29540996

ABSTRACT

'Ageing well' has been highlighted as an important research area by the World Health Organization. In the UK, healthy ageing has been identified as a priority research area by multiple Research Councils and is a key NHS priority. Sarcopaenia, the decline of muscle mass/strength and a key component of healthy ageing, can have a major impact on quality of life and is associated with premature mortality. Increasing protein intake at all stages of the life course may help to reduce the rate of muscle decline and the onset of associated health conditions. However, there is a lack of understanding of the social, demographic and psychological drivers of food choices surrounding protein intake. This report describes the multidisciplinary approach that has been adopted by the Protein for Life project to create a framework for the development of palatable, cost-effective higher-protein foods suitable for an ageing population.

5.
Aliment Pharmacol Ther ; 44(1): 3-15, 2016 07.
Article in English | MEDLINE | ID: mdl-27145394

ABSTRACT

BACKGROUND: Psychological morbidity in young people aged 10-24 years, with inflammatory bowel disease (IBD) is increased, but risk factors for and impacts of this are unclear. AIM: To undertake a systematic literature review of the risk factors for and impact of psychological morbidity in young people with IBD. METHODS: Electronic searches for English-language articles were performed with keywords relating to psychological morbidity according to DSM-IV and subsequent criteria; young people; and IBD in the MEDLINE, PsychInfo, Web of Science and CINAHL databases for studies published from 1994 to September 2014. RESULTS: One thousand four hundred and forty-four studies were identified, of which 30 met the inclusion criteria. The majority measured depression and anxiety symptoms, with a small proportion examining externalising behaviours. Identifiable risk factors for psychological morbidity included: increased disease severity (r(2) = 0.152, P < 0.001), lower socioeconomic status (r(2) = 0.046, P < 0.001), corticosteroids (P ≤ 0.001), parental stress (r = 0.35, P < 0.001) and older age at diagnosis (r = 0.28, P = 0.0006). Impacts of psychological morbidity in young people with IBD were wide-ranging and included abdominal pain (r = 0.33; P < 0.001), sleep dysfunction (P < 0.05), psychotropic drug use (HR 4.16, 95% CI 2.76-6.27), non-adherence to medication (12.6% reduction) and negative illness perceptions (r = -0.43). CONCLUSIONS: Psychological morbidity affects young people with IBD in a range of ways, highlighting the need for psychological interventions to improve outcomes. Identified risk factors provide an opportunity to develop targeted therapies for a vulnerable group. Further research is required to examine groups under-represented in this review, such as those with severe IBD and those from ethnic minorities.


Subject(s)
Anxiety/epidemiology , Depression/epidemiology , Inflammatory Bowel Diseases/psychology , Abdominal Pain/etiology , Humans , Parents/psychology , Risk Factors
6.
Subcell Biochem ; 56: 229-45, 2012.
Article in English | MEDLINE | ID: mdl-22116702

ABSTRACT

Riboflavin (7,8-dimethyl-10-ribitylisoalloxazine; vitamin B2) is a water-soluble vitamin, cofactor derivatives of which (FAD, FMN) act as electron acceptors in the oxidative metabolism of carbohydrate, amino acids and fatty acids and which in the reduced state can donate electrons to complex II of the electron transport chain. This means that riboflavin is essential for energy generation in the aerobic cell, through oxidative phosphorylation. The classic effects of riboflavin deficiency on growth and development have generally been explained in terms of these functions. However, research also suggests that riboflavin may have specific functions associated with cell fate determination, which would have implications for growth and development. In particular, riboflavin depletion interferes with the normal progression of the cell cycle, probably through effects on the expression of regulatory genes, exerted at both the transcriptional and proteomic level.


Subject(s)
Cell Differentiation , Growth and Development , Riboflavin/physiology , Animals , Cell Cycle/drug effects , Cell Differentiation/drug effects , Enterocytes/drug effects , Enterocytes/physiology , Gastrointestinal Tract/drug effects , Gastrointestinal Tract/growth & development , Growth and Development/drug effects , Humans , Riboflavin/chemistry , Riboflavin/pharmacology , Riboflavin Deficiency/complications , Riboflavin Deficiency/metabolism
7.
Aliment Pharmacol Ther ; 29(1): 97-103, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18785988

ABSTRACT

BACKGROUND: The efficacy of probiotics in alleviating the symptoms of irritable bowel syndrome (IBS) appears to be both strain- and dose-related. AIM: To investigate the effect of LAB4, a multistrain probiotic preparation on symptoms of IBS. This probiotic preparation has not previously been assessed in IBS. METHODS: Fifty-two participants with IBS, as defined by the Rome II criteria, participated in this double blind, randomized, placebo-controlled study. Participants were randomized to receive either a probiotic preparation comprising two strains of Lactobacillus acidophilus CUL60 (NCIMB 30157) and CUL21 (NCIMB 30156), Bifidobacterium lactis CUL34 (NCIMB 30172) and Bifidobacterium bifidum CUL20 (NCIMB 30153) at a total of 2.5 × 10(10) cfu/capsule or a placebo for 8 weeks. Participants reported their IBS symptoms using a questionnaire fortnightly during the intervention and at 2 weeks post-intervention. RESULTS: A significantly greater improvement in the Symptom Severity Score of IBS and in scores for quality of life, days with pain and satisfaction with bowel habit was observed over the 8-week intervention period in the volunteers receiving the probiotic preparation than in the placebo group. CONCLUSION: LAB4 multistrain probiotic supplement may benefit subjects with IBS.


Subject(s)
Irritable Bowel Syndrome/therapy , Probiotics/therapeutic use , Adult , Analysis of Variance , Bifidobacterium , Defecation/physiology , Double-Blind Method , Female , Humans , Irritable Bowel Syndrome/physiopathology , Lactobacillus acidophilus , Male , Middle Aged , Placebos , Severity of Illness Index , Surveys and Questionnaires , Time Factors , Treatment Outcome
8.
Appetite ; 51(3): 713-9, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18655817

ABSTRACT

Sodium alginate is a seaweed-derived fibre that has previously been shown to moderate appetite in models of acute feeding. The mechanisms underlying this effect may include slowed gastric clearance and attenuated uptake from the small intestine. In order to assess whether alginate could be effective as a means of appetite control in free-living adults, 68 males and females (BMI range: 18.50-32.81 kg/m(2)) completed this randomised, controlled two-way crossover intervention to compare the effects of 7 day daily ingestion of a strong-gelling sodium alginate formulation against a control. A sodium alginate with a high-guluronate content was chosen because, upon ingestion, it forms a strong gel in the presence of calcium ions. Daily preprandial ingestion of the sodium alginate formulation produced a significant 134.8 kcal (7%) reduction in mean daily energy intake. This reduced energy intake was underwritten by significant reductions in mean daily carbohydrate, sugar, fat, saturated fat and protein intakes. The absence of any significant interaction effects between the main effect of preload type and those of gender, BMI classification and/or timing of preload delivery indicates the efficacy of this treatment for individuals in different settings. These findings suggest a possible role for a strong-gelling sodium alginate formulation in the future management of overweight and obesity.


Subject(s)
Alginates/pharmacology , Dietary Fiber/pharmacology , Energy Intake/drug effects , Gastrointestinal Transit/drug effects , Intestinal Absorption/drug effects , Obesity/prevention & control , Adult , Alginates/administration & dosage , Body Mass Index , Calcium/chemistry , Cross-Over Studies , Dietary Fiber/administration & dosage , Energy Intake/physiology , Female , Gels , Glucuronic Acid/administration & dosage , Glucuronic Acid/pharmacology , Hexuronic Acids/administration & dosage , Hexuronic Acids/pharmacology , Humans , Male , Obesity/therapy , Single-Blind Method , Weight Loss/drug effects , Young Adult
9.
Curr Genomics ; 9(5): 301-11, 2008.
Article in English | MEDLINE | ID: mdl-19471608

ABSTRACT

Sp-family transcription factors are widely expressed in human tissues and involved in the regulation of many cellular processes and response to cellular microenvironment. These responses appear to be mediated by alterations in transcription factor affinity for DNA rather than altered protein level. How might such changes be effected? This review will identify the range of known post-translational modifications (PTMs) of Sp-factors and the sometimes conflicting literature about the roles of PTMs in regulating activity. We will speculate on the interaction between cell environment, chromatin microenvironment and the role of PTM in governing functionality of the proteins and the complexes to which they belong.

10.
Oncogene ; 25(54): 7192-200, 2006 Nov 16.
Article in English | MEDLINE | ID: mdl-16732318

ABSTRACT

Butyrate is a key bioactive product of dietary fibre fermentation thought to play a key role in cancer prevention. One contributory mechanism in this role is the regulation of apoptosis by butyrate. As butyrate shows low levels of toxicity, the mechanisms by which it triggers or regulates apoptosis are of great interest. We and others have shown that the proapoptotic protein BAK is upregulated by butyrate. We show here that this observation is conserved across multiple cell lines, that it occurs in all cells in a population and is at the transcriptional level. We have used a promoter-reporter construct to identify the regulatory regions of the BAK promoter and found that much of the transcriptional activity occurs via a single Sp1/Sp3 binding site. We have shown that both Sp1 and Sp3 bind, but upon butyrate treatment Sp1 binding decreases in favour of Sp3 binding. We speculate that this may be an acetylation-mediated event.


Subject(s)
Apoptosis/physiology , Butyric Acid/metabolism , Colon/metabolism , Sp3 Transcription Factor/metabolism , bcl-2 Homologous Antagonist-Killer Protein/metabolism , Blotting, Western , Caco-2 Cells , Cell Line, Tumor , Dietary Fiber/metabolism , Flow Cytometry , HCT116 Cells , HT29 Cells , Humans , Promoter Regions, Genetic , Reverse Transcriptase Polymerase Chain Reaction , Sp1 Transcription Factor/metabolism , Up-Regulation , bcl-2 Homologous Antagonist-Killer Protein/genetics
12.
Cell Mol Life Sci ; 59(3): 403-9, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11964118

ABSTRACT

Despite being relatively insensitive to environmental insult, the spore is responsive to low concentrations of chemical germinants, which induce germination. The process of bacterial spore germination involves membrane permeability changes, ion fluxes and the activation of enzymes that degrade the outer layers of the spore. A number of components in the spore that are required for the germination response have been identified, including a spore-specific family of receptor proteins (the GerA family), an ion transporter and cortex lytic enzymes. The germinant traverses the outer layers of the spore and interacts with its receptor in the inner membrane to initiate the cascade of germination events, but the molecular details of this signal transduction process remain to be identified.


Subject(s)
Spores, Bacterial/growth & development , Bacterial Proteins/metabolism , Cations, Monovalent/metabolism , Cell Membrane Permeability , Cell Wall/enzymology , Cell Wall/metabolism , Gene Expression Regulation, Bacterial , Genes, Bacterial/genetics , Ion Transport , Membrane Proteins/metabolism , Spores, Bacterial/cytology , Spores, Bacterial/genetics , Spores, Bacterial/metabolism
13.
Oncogene ; 20(52): 7668-76, 2001 Nov 15.
Article in English | MEDLINE | ID: mdl-11753644

ABSTRACT

The pro-apoptotic protein Bak is converted from a latent to an active form by damage-induced signals. This process involves an early exposure of an occluded N-terminal epitope of Bak in intact cells. Here we report a subsequent damage-induced change in Bak, detected using an antibody to the central BH-1 domain. Bak co-immunoprecipitated with Bc1-x(L) both in undamaged cells and early after damage, when the N-terminal epitope was exposed but the BH-1 epitope remained occluded. A subsequent decrease in binding of Bak to Bc1-x(L) correlated with exposure of an epitope in the Bak BH-1 domain. Overexpression of Bc1-x(L) did not affect the kinetics of exposure of the Bak N-terminal epitope but delayed exposure of the BH-1 domain. Cytochrome c release from mitochondria facilitates the activation of apoptotic caspases. The majority of cells with exposed Bak BH-1 domains contained cytosolic cytochrome c. However, a small proportion of cells exhibited exposed Bak BH-1 domains that co-localized with mitochondrial cytochrome c. The data are consistent with a two-step model for the activation of Bak by drug-induced damage signals where dissociation of Bc1-x(L) from the BH-1 domain of Bak occurs immediately prior to or concomitantly with cytochrome c release.


Subject(s)
Apoptosis , Membrane Proteins/chemistry , Proto-Oncogene Proteins c-bcl-2/chemistry , Signal Transduction , Amino Acid Chloromethyl Ketones/pharmacology , Caspase Inhibitors , Cysteine Proteinase Inhibitors/pharmacology , Cytochrome c Group/metabolism , Epitopes, B-Lymphocyte/chemistry , Epitopes, B-Lymphocyte/immunology , Epitopes, B-Lymphocyte/metabolism , Humans , Membrane Proteins/immunology , Membrane Proteins/metabolism , Mitochondria/metabolism , Protein Structure, Tertiary , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Proto-Oncogene Proteins c-bcl-2/immunology , Proto-Oncogene Proteins c-bcl-2/metabolism , Tumor Cells, Cultured , bcl-2 Homologous Antagonist-Killer Protein , bcl-X Protein
14.
EMBO J ; 20(22): 6306-15, 2001 Nov 15.
Article in English | MEDLINE | ID: mdl-11707402

ABSTRACT

Sequential steps in the activation of the pro-apoptotic protein Bax are described for cells with different sensitivity to cytotoxins. SH-EP1 and SH-SY5Y human neuroblastoma cells, derived from a single precursor cell line, differed in their sensitivity to taxol but showed the same sensitivity to cisplatin. Both drugs, in both cell lines, induced exposure of a constitutively occluded N-terminal epitope of Bax. This was reversible and occurred before the translocation of cytosolic Bax to mitochondria. The N-terminal change in Bax, its subsequent movement to mitochondria and its dimerization/complex formation were insufficient for commitment to death, occurring in the same proportion of cells that either maintained (SH-SY5Y) or lost (SH-EP1) clonogenic survival after taxol treatment. Suppression of taxol-induced apoptosis occurred upstream of cytochrome c release from mitochondria in SH-SY5Y cells. The data suggest that a further drug damage-induced event occurs after Bax dimerization/complex formation but prior to cytochrome c release. This event was absent in the taxol-resistant cells.


Subject(s)
Mitochondria/metabolism , Proto-Oncogene Proteins c-bcl-2 , Proto-Oncogene Proteins/chemistry , Proto-Oncogene Proteins/genetics , Antineoplastic Agents/pharmacology , Antineoplastic Agents, Phytogenic/pharmacology , Apoptosis , Blotting, Western , Caspases/metabolism , Cell Lineage , Cell Survival , Cisplatin/pharmacology , Cytochrome c Group/metabolism , Dimerization , Dose-Response Relationship, Drug , Enzyme Activation , Epitopes , Flow Cytometry , Humans , Microscopy, Fluorescence , Neuroblastoma/metabolism , Paclitaxel/pharmacology , Protein Structure, Tertiary , Protein Transport , Subcellular Fractions , Time Factors , Tumor Cells, Cultured , Up-Regulation , bcl-2-Associated X Protein
15.
J Bacteriol ; 183(14): 4317-22, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11418573

ABSTRACT

The GerAA, -AB, and -AC proteins of the Bacillus subtilis spore are required for the germination response to L-alanine as the sole germinant. They are likely to encode the components of the germination apparatus that respond directly to this germinant, mediating the spore's response; multiple homologues of the gerA genes are found in every spore former so far examined. The gerA operon is expressed in the forespore, and the level of expression of the operon appears to be low. The GerA proteins are predicted to be membrane associated. In an attempt to localize GerA proteins, spores of B. subtilis were broken and fractionated to give integument, membrane, and soluble fractions. Using antibodies that detect Ger proteins specifically, as confirmed by the analysis of strains lacking GerA and the related GerB proteins, the GerAA protein and the GerAC+GerBC protein homologues were localized to the membrane fraction of fragmented spores. The spore-specific penicillin-binding protein PBP5*, a marker for the outer forespore membrane, was absent from this fraction. Extraction of spores to remove coat layers did not release the GerAC or AA protein from the spores. Both experimental approaches suggest that GerAA and GerAC proteins are located in the inner spore membrane, which forms a boundary around the cellular compartment of the spore. The results provide support for a model of germination in which, in order to initiate germination, germinant has to permeate the coat and cortex of the spore and bind to a germination receptor located in the inner membrane.


Subject(s)
Bacillus subtilis/chemistry , Bacterial Proteins/analysis , Membrane Proteins , Amino Acid Sequence , Antibodies, Bacterial/immunology , Bacterial Proteins/immunology , Chemical Fractionation , Molecular Sequence Data , Spores, Bacterial
17.
J Cell Biol ; 144(5): 903-14, 1999 Mar 08.
Article in English | MEDLINE | ID: mdl-10085290

ABSTRACT

Investigation of events committing cells to death revealed that a concealed NH2-terminal epitope of the pro-apoptotic protein Bak became exposed in vivo before apoptosis. This occurred after treatment of human Jurkat or CEM-C7A T-lymphoma cells with the mechanistically disparate agents staurosporine, etoposide or dexamethasone. The rapid, up to 10-fold increase in Bak-associated immunofluorescence was measured with epitope-specific monoclonal antibodies using flow cytometry and microscopy. In contrast, using a polyclonal antibody to Bak, immunofluorescence was detected both before and after treatment. There were no differences in Bak protein content nor in subcellular location before or after treatment. Immunofluorescence showed Bcl-xL and Bak were largely associated with mitochondria and in untreated cells they coimmunoprecipitated in the presence of nonioinic detergent. This association was significantly decreased after cell perturbation suggesting that Bcl-xL dissociation from Bak occurred on exposure of Bak's NH2 terminus. Multiple forms of Bak protein were observed by two dimensional electrophoresis but these were unchanged by inducers of apoptosis. This indicated that integration of cellular damage signals did not take place directly on the Bak protein. Release of proteins, including Bcl-xL, from Bak is suggested to be an important event in commitment to death.


Subject(s)
Apoptosis , Membrane Proteins/metabolism , Caspases/metabolism , Cell Cycle , Dexamethasone/pharmacology , Electrophoresis, Gel, Two-Dimensional , Enzyme Activation , Epitopes/chemistry , Etoposide/pharmacology , Humans , Membrane Proteins/chemistry , Microscopy, Fluorescence , Protein Conformation , Staurosporine/pharmacology , Subcellular Fractions/metabolism , Tumor Cells, Cultured , bcl-2 Homologous Antagonist-Killer Protein
18.
Lett Appl Microbiol ; 23(5): 290-4, 1996 Nov.
Article in English | MEDLINE | ID: mdl-8987707

ABSTRACT

The alanine-stimulated spore germination responses of Bacillus subtilis 168 have been dissected by combining physiological and genetical approaches. From the analyses the authors infer that there are three classes of alanine response. Two of the responses are mediated via the GerA proteins, with and without germinal adjuncts, the third is mediated via the GerB proteins and obligately requires adjuncts.


Subject(s)
Alanine/pharmacology , Bacillus subtilis/physiology , Bacterial Proteins/physiology , Spores, Bacterial/physiology
19.
Microbiology (Reading) ; 140 ( Pt 11): 3079-83, 1994 Nov.
Article in English | MEDLINE | ID: mdl-7812448

ABSTRACT

The gerB spore germination operon of Bacillus subtilis 168 is a homologue of the gerA spore germination operon. The expression and regulation of the gerB operon has been examined using a lacZ transcriptional fusion and the transcriptional start defined. The gerB operon is expressed during sporulation under the control of RNA polymerase containing the forespore-specific sigma factor, delta G. This is a further homology to the gerA operon, which is similarly regulated. It is predicted from the localization of expression and the encoded primary sequences that the GerB proteins are located at the inner spore membrane.


Subject(s)
Bacillus subtilis/genetics , Bacterial Proteins/genetics , Gene Expression Regulation, Bacterial , Operon/genetics , Spores, Bacterial/genetics , Bacterial Proteins/biosynthesis , Base Sequence , Consensus Sequence , DNA-Directed RNA Polymerases/metabolism , Molecular Sequence Data , Promoter Regions, Genetic/genetics , RNA, Messenger/genetics , Sigma Factor/metabolism , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...